AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.890
+0.160 (5.86%)
At close: Nov 4, 2024, 4:00 PM
2.740
-0.150 (-5.19%)
Pre-market: Nov 5, 2024, 9:14 AM EST
AbCellera Biologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 126.64 | 133.32 | 386.54 | 476.14 | 594.12 | 7.55 | Upgrade
|
| Short-Term Investments | 516.5 | 627.27 | 499.95 | 246.84 | - | - | Upgrade
|
| Cash & Short-Term Investments | 643.14 | 760.59 | 886.49 | 722.98 | 594.12 | 7.55 | Upgrade
|
| Cash Growth | -18.16% | -14.20% | 22.62% | 21.69% | 7765.96% | -27.68% | Upgrade
|
| Accounts Receivable | 31.37 | 30.59 | 38.59 | 160.58 | 213.24 | 2.12 | Upgrade
|
| Other Receivables | - | 33.79 | 64.82 | 14.28 | 0.49 | 2.25 | Upgrade
|
| Receivables | 31.37 | 64.38 | 103.41 | 174.86 | 213.73 | 4.38 | Upgrade
|
| Inventory | - | 1.11 | 1.53 | 1.67 | 1.41 | 0.16 | Upgrade
|
| Prepaid Expenses | - | 20.91 | 9.06 | 5.29 | 4.07 | 0.55 | Upgrade
|
| Restricted Cash | 25 | 25 | 25 | 25 | - | - | Upgrade
|
| Total Current Assets | 742.88 | 871.99 | 1,025 | 929.8 | 813.33 | 12.64 | Upgrade
|
| Property, Plant & Equipment | 331.26 | 287.7 | 217.26 | 111.62 | 17.92 | 8.48 | Upgrade
|
| Long-Term Investments | 84.08 | 65.94 | 34.42 | 32.31 | 20.03 | - | Upgrade
|
| Goodwill | 47.81 | 47.81 | 47.81 | 47.81 | 31.5 | - | Upgrade
|
| Other Intangible Assets | 52.58 | 120.43 | 131.5 | 148.39 | 115.15 | - | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 5.9 | - | Upgrade
|
| Other Long-Term Assets | 134.22 | 80.34 | 40.83 | 30.64 | 1.71 | 0.59 | Upgrade
|
| Total Assets | 1,393 | 1,488 | 1,541 | 1,319 | 1,006 | 23.49 | Upgrade
|
| Accounts Payable | 53.77 | 25.51 | 14.83 | 14.92 | 7.32 | 1.64 | Upgrade
|
| Accrued Expenses | - | 10.8 | 25.8 | 26.54 | 29.13 | - | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.39 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 2.08 | Upgrade
|
| Current Portion of Leases | - | 6.16 | 5.58 | 3.65 | 0.68 | 0.42 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 35.68 | 36.15 | - | Upgrade
|
| Current Unearned Revenue | 5.58 | 26.07 | 27.9 | 12.01 | 7.53 | 3.27 | Upgrade
|
| Other Current Liabilities | 20.22 | 50.48 | 44.21 | 27.87 | 22.68 | 0.1 | Upgrade
|
| Total Current Liabilities | 79.57 | 119.01 | 118.32 | 120.68 | 103.49 | 7.9 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 1.36 | Upgrade
|
| Long-Term Leases | 66.27 | 71.22 | 76.68 | 36.41 | 3.72 | 2.64 | Upgrade
|
| Long-Term Unearned Revenue | 150.15 | 104.11 | 60.32 | 60.76 | 25.89 | 1.34 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 12.78 | 30.61 | 33.18 | 37.37 | 26.16 | - | Upgrade
|
| Other Long-Term Liabilities | 5.97 | 10.82 | 19.14 | 37.62 | 15.77 | - | Upgrade
|
| Total Liabilities | 314.73 | 335.78 | 307.63 | 292.84 | 175.03 | 13.24 | Upgrade
|
| Common Stock | 772.83 | 753.2 | 734.37 | 722.43 | 710.39 | 5.12 | Upgrade
|
| Additional Paid-In Capital | 155.35 | 121.05 | 74.12 | 35.36 | 5.92 | 2.3 | Upgrade
|
| Retained Earnings | 151.14 | 279.79 | 426.19 | 267.67 | 114.2 | -4.72 | Upgrade
|
| Comprehensive Income & Other | -1.23 | -1.72 | -1.39 | 0.28 | - | - | Upgrade
|
| Total Common Equity | 1,078 | 1,152 | 1,233 | 1,026 | 830.51 | 2.71 | Upgrade
|
| Shareholders' Equity | 1,078 | 1,152 | 1,233 | 1,026 | 830.51 | 10.25 | Upgrade
|
| Total Liabilities & Equity | 1,393 | 1,488 | 1,541 | 1,319 | 1,006 | 23.49 | Upgrade
|
| Total Debt | 66.27 | 77.38 | 82.26 | 40.07 | 4.39 | 6.89 | Upgrade
|
| Net Cash (Debt) | 576.87 | 683.21 | 804.23 | 682.91 | 589.73 | 0.66 | Upgrade
|
| Net Cash Growth | -18.18% | -15.05% | 17.76% | 15.80% | 88982.48% | -90.55% | Upgrade
|
| Net Cash Per Share | 1.97 | 2.36 | 2.55 | 2.15 | 2.24 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 295.16 | 292.78 | 287.69 | 283.92 | 269.5 | 154.09 | Upgrade
|
| Total Common Shares Outstanding | 295.16 | 290.82 | 286.85 | 283.26 | 269.5 | 151.68 | Upgrade
|
| Working Capital | 663.32 | 752.97 | 907.17 | 809.12 | 709.84 | 4.75 | Upgrade
|
| Book Value Per Share | 3.65 | 3.96 | 4.30 | 3.62 | 3.08 | 0.02 | Upgrade
|
| Tangible Book Value | 977.71 | 984.09 | 1,054 | 829.54 | 683.86 | 2.71 | Upgrade
|
| Tangible Book Value Per Share | 3.31 | 3.38 | 3.67 | 2.93 | 2.54 | 0.02 | Upgrade
|
| Land | - | 53.41 | 53.41 | 33.04 | - | - | Upgrade
|
| Buildings | - | 43.95 | 11.36 | 1.21 | - | - | Upgrade
|
| Machinery | - | 73.87 | 49.56 | 26.65 | 15.87 | 6.22 | Upgrade
|
| Leasehold Improvements | - | 73.94 | 40.57 | 22.75 | 3.71 | 2.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.